Your browser doesn't support javascript.
loading
Quantitative analysis of MGMT promoter methylation in glioblastoma suggests nonlinear prognostic effect.
Gibson, David; Ravi, Akshay; Rodriguez, Eduardo; Chang, Susan; Oberheim Bush, Nancy; Taylor, Jennie; Clarke, Jennifer; Solomon, David; Scheffler, Aaron; Witte, John; Lambing, Hannah; Okada, Hideho; Berger, Mitchel; Chehab, Farid; Butowski, Nicholas A.
Affiliation
  • Gibson D; Department of Neurological Surgery, Division of Neuro-Oncology, University of California, San Francisco, California, USA.
  • Ravi A; Department of Neurological Surgery, Division of Neuro-Oncology, University of California, San Francisco, California, USA.
  • Rodriguez E; Department of Neurological Surgery, Division of Neuro-Oncology, University of California, San Francisco, California, USA.
  • Chang S; Department of Neurological Surgery, Division of Neuro-Oncology, University of California, San Francisco, California, USA.
  • Oberheim Bush N; Department of Neurological Surgery, Division of Neuro-Oncology, University of California, San Francisco, California, USA.
  • Taylor J; Department of Neurological Surgery, Division of Neuro-Oncology, University of California, San Francisco, California, USA.
  • Clarke J; Department of Neurological Surgery, Division of Neuro-Oncology, University of California, San Francisco, California, USA.
  • Solomon D; Department of Neurological Surgery, Division of Neuro-Oncology, University of California, San Francisco, California, USA.
  • Scheffler A; Department of Pathology, University of California, San Francisco, California, USA.
  • Witte J; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA.
  • Lambing H; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA.
  • Okada H; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA.
  • Berger M; Department of Neurological Surgery, Division of Neuro-Oncology, University of California, San Francisco, California, USA.
  • Chehab F; Department of Neurological Surgery, Division of Neuro-Oncology, University of California, San Francisco, California, USA.
  • Butowski NA; Institute for Human Genetics, University of California, San Francisco, California, USA.
Neurooncol Adv ; 5(1): vdad115, 2023.
Article de En | MEDLINE | ID: mdl-37899778
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Neurooncol Adv Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Neurooncol Adv Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique